EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2

Federica Bono iD, Zaira Tomasoni, Veronica Mutti iD, Giulia Sbrini, Rajesh Kumar, Francesca Longhena iD, Chiara Fiorentini iD, Cristina Missale

Biomolecules · 2023

DOI: 10.3390/biom13030473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Federica Bono und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Dopamine, Levodopa. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Michael J. Fox Foundation for Parkinson Research, New York, USA, Fondazione CARIPLO (2012–2014), University of Brescia Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heteromer composed of dopamine D1 and D3 receptors (D1R–D3R) has been defined as a structure able to trigger Erk1/2 and Akt signaling in a G protein-independent, beta-arrestin 1-dependent way that is physiologically expressed in the ventral striatum and is likely involved in the control of locomotor activity. Indeed, abnormal levels of D1R-D3R heteromer in the dorsal striatum have been correlated with the development of L-DOPA-induced dyskinesia (LID) in Parkinson’s disease patients, a motor complication associated with striatal D1R signaling, thus requiring Gs protein and PKA activity to activate Erk1/2. Therefore, to clarify the role of the D1R/D3R heteromer in LID, we investigated the signaling pathway induced by the heteromer using transfected cells and primary mouse striatal neurons. Collectively, we found that in both the cell models, D1R/D3R heteromer-induced activation of Erk1/2 exclusively required the D1R molecular effectors, such as Gs protein and PKA, with the contribution of the phosphatase Shp-2 and beta-arrestins, indicating that heterodimerization with the D3R abolishes the specific D3R-mediated signaling but strongly allows D1R signals. Therefore, while in physiological conditions the D1R/D3R heteromer could represent a mechanism that strengthens the D1R activity, its pathological expression may contribute to the abnormal PKA-Shp-2-Erk1/2 pathway connected with LID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DopamineLevodopaAnimalsMicebeta-Arrestin 1beta-ArrestinsGTP-Binding ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine PhosphatasesReceptors, Dopamine D1Receptors, Dopamine D3Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Receptors, Cytoplasmic and Nuclear

Stichwörter der Autor:innen

G protein-coupled receptors (GPCRs)L-DOPA-induced dyskinesia (LID)beta-arrestindopamine receptorsheterodimerizationstriatumtyrosine phosphatase Shp-2

Substanzen

beta-Arrestin 1beta-ArrestinsDopamineGTP-Binding ProteinsLevodopaProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine PhosphatasesReceptors, Dopamine D1Receptors, Dopamine D3Mapk1 protein, mouse

Autor:innen und Institutionen

  • Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
  • Seattle Children's Research Institute, 1920 Terry Ave., Seattle, WA 98101, USA.

ORCID-Profile: Federica Bono, Veronica Mutti, Francesca Longhena, Chiara Fiorentini

Förderung

  • The Michael J. Fox Foundation for Parkinson Research, New York, USA
  • Fondazione CARIPLO (2012–2014)
  • University of Brescia Italy

Zitieren

APA

Bono, F., Tomasoni, Z., Mutti, V., Sbrini, G., Kumar, R., Longhena, F., Fiorentini, C., & Missale, C. (2023). G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2. Biomolecules. https://doi.org/10.3390/biom13030473

Vancouver

Bono F, Tomasoni Z, Mutti V, Sbrini G, Kumar R, Longhena F, et al. G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2. Biomolecules. 2023. doi:10.3390/biom13030473

BibTeX
@article{Bono2023,
  author = {Bono, Federica and Tomasoni, Zaira and Mutti, Veronica and Sbrini, Giulia and Kumar, Rajesh and Longhena, Francesca and Fiorentini, Chiara and Missale, Cristina},
  title = {G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13030473}
}
Kostenlos starten →